Development and longevity of antibodies against SARS-CoV-2 in kidney transplant recipients after symptomatic COVID-19

Transpl Infect Dis. 2021 Aug;23(4):e13646. doi: 10.1111/tid.13646. Epub 2021 Jun 1.
No abstract available

Keywords: COVID-19; anti-SARS-CoV-2 antibodies; immunological response; kidney transplantation.

Publication types

  • Letter
  • Comment

MeSH terms

  • Antibodies
  • COVID-19*
  • Humans
  • Kidney Transplantation* / adverse effects
  • SARS-CoV-2
  • Transplant Recipients

Substances

  • Antibodies